EZR and osteosarcoma: A pool of studies published between 2007 and 2010 on the association between ezrin immunoexpression and patient's survival, serum alkaline phosphatase (ALP) level, histological response to adjuvant chemotherapy and recurrence in osteosarcoma were analyzed.